摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(Hydroxymethyl)-6-(1-hydroxytrideca-5,7,9,11-tetrayn-2-yloxy)oxane-3,4,5-triol

中文名称
——
中文别名
——
英文名称
2-(Hydroxymethyl)-6-(1-hydroxytrideca-5,7,9,11-tetrayn-2-yloxy)oxane-3,4,5-triol
英文别名
——
2-(Hydroxymethyl)-6-(1-hydroxytrideca-5,7,9,11-tetrayn-2-yloxy)oxane-3,4,5-triol化学式
CAS
——
化学式
C19H22O7
mdl
——
分子量
362.4
InChiKey
LIVZHGSTYIVZNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    26
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    120
  • 氢给体数:
    5
  • 氢受体数:
    7

文献信息

  • Butanol extract of Bidens pilosa
    申请人:Yang Wen-Chin
    公开号:US20070053998A1
    公开(公告)日:2007-03-08
    A compound of the formula: wherein R 1 is H, alkyl, aryl, or cyclyl; R 2 is pyranose; R 3 is H or alkyl; m is 2, 3, 4, 5, or 6; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, 4; and p is 1, 2, 3, or 4. Also disclosed is use of the compound to inhibit Th1 differentiation, promote Th2 differentiation, and treat certain disorders.
  • Polyacetylenic Compounds
    申请人:Yang Wen-Chin
    公开号:US20080193568A1
    公开(公告)日:2008-08-14
    This invention relates to a method of treating type II diabetes with a polyacetylenic compound of the following formula: in which R 1 is H, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 3 -C 20 cycloalkyl, C 3 -C 20 cycloalkenyl, C 1 -C 20 heterocycloalkyl, C 1 -C 20 heterocycloalkenyl, aryl, or heteroaryl; R 2 is H or a monosaccharide residue; R 3 is H or C 1 -C 10 alkyl; m is 2, 3, or 4; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, or 4; and p is 1, 2, 3, or 4.
  • BUTANOL EXTRACT OF BIDENS PILOSA
    申请人:Yang Wen-Chin
    公开号:US20090062216A1
    公开(公告)日:2009-03-05
    A method of treating a Th1-mediated disorder includes administering to a subject in need of the treatment an effective amount of a compound of the formula I: wherein R 1 is H, alkyl, aryl, or cyclyl; R 2 is pyranose; R 3 is H or alkyl; m is 2, 3, 4, 5, or 6; n is 0, 1, 2, or 3; o is 0, 1, 2, 3, 4; p is 1, 2, 3, or 4; and the Th1-mediated disorder is non-obese diabetes, Crohn's colitis, autoimmune hemolytic anemia, rheumatoid arthritis, autoimmune encephalitis, multiple sclerosis, or autoimmune myocarditis. Also disclosed is a pharmaceutical composition including a compound of formula I above and a pharmaceutically acceptable carrier.
  • BIDENS PILOSA AND POLYACETYLENIC COMPOUNDS FOR PREVENTION AND TREATMENT OF COCCIDIOSIS
    申请人:ACADEMIA SINICA
    公开号:US20140308378A1
    公开(公告)日:2014-10-16
    A composition for use in prevention, inhibition and/or treatment of coccidiosis in an animal is disclosed. The composition comprises an effective amount of Bidens pilosa, an active constituent thereof, or an active compound isolated therefrom. In another aspect, a composition for use in preventing and/or treating coccidiosis, and/or enhancing growth in an animal is disclosed, the composition comprising an animal feed and an effective amount of Bidens pilosa, or an isolated active constituent comprising a polyacetylenic compound.
  • BIDENS PILOSA AND POLYACETYLENIC COMPOUNDS FOR PREVENTION AND TREATMENT OF COCCIDIOSIS
    申请人:ACADEMIA SINICA
    公开号:US20150272975A1
    公开(公告)日:2015-10-01
    A composition for use in prevention, inhibition and/or treatment of coccidiosis in an animal is disclosed. The composition comprises an effective amount of Bidens pilosa , an active constituent thereof, or an active compound isolated therefrom.
查看更多